Drug Interactions & Adverse Effects

Resources: 31

Hepatitis C Online

Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the C...

Publication Date

ART Drug Interactions

Training slides review potential ARV drug-drug interactions and identify resources for the evaluation of drug-drug interactions.

Documents with previ...

Publication Date

ART Adherence


This Training Presentation will compare and contrast factors that affect medication adherence and apply a patient centered approach to ant...

Publication Date

Case Based Learning

These training slides guide providers in decision making on managing antiretroviral therapy and switching treatments, as well as discussions on preven...

Publication Date

HIV Medications Overview

These guideline slides compare and contrast various antiretroviral therapy (ART) options when initiating treatment for people with HIV, as well as ind...

Publication Date

Resources: 3

Articles: 7

Cobicistat and Stribild Use in Patients with Renal Insufficiency

Co-Author: Susa Coffey, MD; Medical Editor, AETC National Resource Center

An open-label study is evaluating the renal safety of elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild, or the "quad" pill) and cobicistat. For those patients with mild-to-moderate renal impairment (estimated glomerula...


Pitavastatin and Darunavir/Ritonavir

Coauthor: Susa Coffey, MD; Medical Editor, AETC National Resource Center

Treatment of dyslipidemia is often complicated by drug interactions between statins and antiretrovirals. Pitavastatin is one of the newer statins approved and is one of the few that is not metabolized primarily by the CYP450 3A4...


Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)

Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain inter...